Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.36), $0.49 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $163.62 thousand.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.